Socioeconomic deprivation is stalling improvements in outcomes for multiple myeloma patients in New Zealand, especially those from Maori and Pacific Island backgrounds. An analysis of cases from the New Zealand Cancer Registry between January 2004 and December 2016 confirmed the incidence of multiple myeloma is increasing. The age-standardized incidence rate (ASIR) increased from 4.01 per 100,000 in ...
Benefits from bortezomib not available to all
By Mardi Chapman
17 Oct 2019